Abiomed Inc

(NASDAQ: ABMD)
  • Trade now
  • Add to Watchlist
  • Get Chart
  • Print report
22.97 Down -0.14 -0.61%
Find financial results for:
MORE ON ABMD
 Annual  Interim
2013 2012 2011 2010 2009
Period End Date 03/31/2013 03/31/2012 03/31/2011 03/31/2010 03/31/2009
Period Length 12 Months 12 Months 12 Months 12 Months 12 Months
Stmt Source 8-K 10-K 10-K 10-K 10-K
Stmt Source Date 05/02/2013 06/04/2012 06/02/2011 06/08/2010 06/08/2009
Stmt Update Type Updated Updated Updated Updated Updated
           
Revenue 158.12 126.38 101.15 85.71 73.21
Other Revenue, Total 0.0 0.0 0.0 0.0 0.0
Total Revenue 158.12 126.38 101.15 85.71 73.21
           
Cost of Revenue, Total 31.6 24.51 21.98 22.53 20.44
Gross Profit 126.53 101.87 79.17 63.18 52.77
           
Selling/General/Administrative Expenses, Total 84.23 71.71 62.29 60.84 55.36
Research & Development 25.65 27.16 26.68 25.95 25.33
Depreciation/Amortization 0.11 1.48 1.4 1.47 1.61
Interest Expense (Income), Net Operating 0.0 0.0 0.0 0.0 0.0
Unusual Expense (Income) 0.0 0.0 0.0 0.0 0.0
Other Operating Expenses, Total 0.0 0.0 0.0 0.0 0.0
Operating Income 16.54 1.52 -11.19 -25.08 -29.52
           
Interest Income (Expense), Net Non-Operating 0.0 0.0 0.0 0.0 0.0
Gain (Loss) on Sale of Assets 0.0 0.0 0.46 6.39 0.31
Other, Net 0.33 0.01 -0.14 -0.04 -0.24
Income Before Tax 16.86 2.54 -10.86 -18.35 -30.85
           
Income Tax - Total 1.85 1.05 0.89 0.67 0.75
Income After Tax 15.01 1.5 -11.76 -19.02 -31.6
           
Minority Interest 0.0 0.0 0.0 0.0 0.0
Equity In Affiliates 0.0 0.0 0.0 0.0 0.0
U.S. GAAP Adjustment 0.0 0.0 0.0 0.0 0.0
Net Income Before Extra. Items 15.01 1.5 -11.76 -19.02 -31.6
           
Total Extraordinary Items
0.0 0.0 0.0 0.0 0.0
Accounting Change 0.0 0.0 0.0 0.0 0.0
Net Income 15.01 1.5 -11.76 -19.02 -31.6
           
Total Adjustments to Net Income
0.0 0.0 0.0 0.0 0.0
Preferred Dividends 0.0 0.0 0.0 0.0 0.0
General Partners Distributions 0.0 0.0 0.0 0.0 0.0
           
Basic Weighted Average Shares 39.11 38.37 37.17 36.88 34.88
Basic EPS Excluding Extraordinary Items 0.38 0.04 -0.32 -0.52 -0.91
Basic EPS Including Extraordinary Items 0.38 0.04 -0.32 -0.52 -0.91
           
Diluted Weighted Average Shares 41.05 40.17 37.17 36.88 34.88
Diluted EPS Excluding Extrordinary Items 0.37 0.04 -0.32 -0.52 -0.91
Diluted EPS Including Extraordinary Items 0.37 0.04 -0.32 -0.52 -0.91
           
Dividends per Share - Common Stock Primary Issue 0.0 0.0 0.0 0.0 0.0
Dividends per Share - Common Stock Issue 2 0.0 0.0 0.0 0.0 0.0
Gross Dividends - Common Stock 0.0 0.0 0.0 0.0 0.0
Interest Expense, Supplemental 0.0 0.0 0.0 0.0 0.0
Depreciation, Supplemental 0.0 2.34 1.9 2.5 2.1
           
Normalized EBITDA 16.65 5.34 -7.89 -21.11 -25.81
Normalized EBIT 16.54 1.52 -11.19 -25.08 -29.52
Normalized Income Before Tax 16.86 2.54 -11.32 -24.74 -31.16
Normalized Income After Taxes 15.01 1.5 -12.05 -23.18 -31.8
Normalized Income Available to Common 15.01 1.5 -12.05 -23.18 -31.8
           
Basic Normalized EPS 0.38 0.04 -0.32 -0.63 -0.91
Diluted Normalized EPS 0.37 0.04 -0.32 -0.63 -0.91
Amortization of Acquisition Cost 0.0 0.0 0.0 0.0 0.0
Amortization of Intangibles 0.11 1.48 1.4 1.47 1.61

Financial data in USD
Values in Millions (Except for per share items)

Business Type: Industry

Financial statements are prepared in this standard format to allow direct comparisons of all companies and industries across multiple time frames.

See 10K and 10Q SEC Filings for as reported statements

DATA PROVIDERS

Copyright © 2013 Microsoft. All rights reserved.

Quotes are real-time for NASDAQ, NYSE and AMEX. See delay times for other exchanges.

Fundamental company data and historical chart data provided by Thomson Reuters (click for restrictions). Real-time quotes provided by BATS Exchange. Real-time index quotes and delayed quotes supplied by Interactive Data Real-Time Services. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations data provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by SIX Financial Information.

Japanese stock price data provided by Nomura Research Institute Ltd.; quotes delayed 20 minutes. Canadian fund data provided by CANNEX Financial Exchanges Ltd.